Luye Pharmaceutical (02186) subsidiary completed the issuance of 1.5 million exchangeable preferred shares

According to the Zhitong Finance App, Luye Pharmaceutical (02186) issued an announcement. On December 12, 2025, according to the terms of the subscription agreement, the issuance of exchangeable preferred shares has been completed. The issuer Luye Geneora Holding Limited (a wholly-owned subsidiary of the Company) has allocated and issued 1.5 million exchangeable preferred shares to subscribers.

These exchangeable preferred shares can be exchanged for existing shares of Boan Biotech held by the Group, and do not involve the issuance of any new shares by Boan Biotech. Based on the initial exchange price of HK$11.718, the maximum number of shares that can be delivered after exchanging all exchangeable preferred shares is 100,486,431 shares, accounting for about 16.15% of the total number of shares issued by Boan Biotech as of the date of this announcement.